BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22527232)

  • 1. Quality of life and depression in multiple sclerosis patients: longitudinal results of the BetaPlus study.
    Pozzilli C; Schweikert B; Ecari U; Oentrich W; Bugge JP
    J Neurol; 2012 Nov; 259(11):2319-28. PubMed ID: 22527232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supportive strategies to improve adherence to IFN β-1b in multiple sclerosis--results of the βPlus observational cohort study.
    Pozzilli C; Schweikert B; Ecari U; Oentrich W;
    J Neurol Sci; 2011 Aug; 307(1-2):120-6. PubMed ID: 21636099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with interferon beta-1b improves quality of life in multiple sclerosis.
    Rice GP; Oger J; Duquette P; Francis GS; Bélanger M; Laplante S; Grenier JF
    Can J Neurol Sci; 1999 Nov; 26(4):276-82. PubMed ID: 10563212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics of middle-aged and older patients with MS treated with interferon beta-1b: post-hoc analysis of a 2-year, prospective, international, observational study.
    Patti F; Penaherrera JN; Zieger L; Wicklein EM
    BMC Neurol; 2021 Aug; 21(1):324. PubMed ID: 34425763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reduction of injection site reactions in multiple sclerosis (MS) patients newly started on interferon beta 1b therapy with two different devices].
    Brochet B; Lemaire G; Beddiaf A;
    Rev Neurol (Paris); 2006 Jun; 162(6-7):735-40. PubMed ID: 16840982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quality-of-life effects of interferon beta-1b in multiple sclerosis. An extended Q-TWiST analysis.
    Schwartz CE; Coulthard-Morris L; Cole B; Vollmer T
    Arch Neurol; 1997 Dec; 54(12):1475-80. PubMed ID: 9400356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coping strategies and quality of life in Mexican multiple sclerosis patients: Physical, psychological and social factors relationship.
    Hernández-Ledesma AL; Rodríguez-Méndez AJ; Gallardo-Vidal LS; Trejo-Cruz G; García-Solís P; Dávila-Esquivel FJ
    Mult Scler Relat Disord; 2018 Oct; 25():122-127. PubMed ID: 30071505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of betaplus program on patient treatment satisfaction with interferon beta-1b in multiple sclerosis: Multicentric cross-sectional survey in the western Balkan countries.
    Drulovic J; Cukic M; Grgic S; Dincic E; Raicevic R; Nadj C; Toncev G; Vojinovic S; Mesaros S; Kisic Tepavcevic D; Dujmovic I; Tadic D; Miletic-Drakulic S; Dackovic J; Kostic S; Erakovic J; Sakalas L; Savic D; Suknjaja V; Martinovic V; Maric G; Pekmezovic T
    Mult Scler Relat Disord; 2017 Jan; 11():56-61. PubMed ID: 28104258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an electronic diary for improvement of adherence to interferon beta-1b in patients with multiple sclerosis: design and baseline results of an observational cohort study.
    Zettl UK; Bauer-Steinhusen U; Glaser T; Hechenbichler K; Limmroth V;
    BMC Neurol; 2013 Sep; 13():117. PubMed ID: 24011220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Religious coping methods predict depression and quality of life among end-stage renal disease patients undergoing hemodialysis: a cross-sectional study.
    Santos PR; Capote Júnior JRFG; Cavalcante Filho JRM; Ferreira TP; Dos Santos Filho JNG; da Silva Oliveira S
    BMC Nephrol; 2017 Jun; 18(1):197. PubMed ID: 28623903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coping strategies, psychological variables and their relationship with quality of life in multiple sclerosis.
    Goretti B; Portaccio E; Zipoli V; Hakiki B; Siracusa G; Sorbi S; Amato MP
    Neurol Sci; 2009 Feb; 30(1):15-20. PubMed ID: 19153648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Interferon beta treatment on quality of life in multiple sclerosis patients.
    Simone IL; Ceccarelli A; Tortorella C; Bellacosa A; Pellegrini F; Plasmati I; De Caro MF; Lopez M; Girolamo F; Livrea P
    Health Qual Life Outcomes; 2006 Dec; 4():96. PubMed ID: 17163989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coping strategies, depressive symptoms and quality of life in hypertensive patients: mediational and prospective relations.
    Rueda B; Pérez-García AM
    Psychol Health; 2013; 28(10):1152-70. PubMed ID: 23679200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial.
    Schippling S; O'Connor P; Knappertz V; Pohl C; Bogumil T; Suarez G; Cook S; Filippi M; Hartung HP; Comi G; Jeffery DR; Kappos L; Goodin DS; Arnason B
    J Neurol; 2016 Jul; 263(7):1418-26. PubMed ID: 27177997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life during the first 6 months of interferon-beta treatment in patients with MS.
    Arnoldus JH; Killestein J; Pfennings LE; Jelles B; Uitdehaag BM; Polman CH
    Mult Scler; 2000 Oct; 6(5):338-42. PubMed ID: 11064444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression, fatigue and disability are independently associated with quality of life in patients with multiple Sclerosis: Results of a cross-sectional study.
    Schmidt S; Jöstingmeyer P
    Mult Scler Relat Disord; 2019 Oct; 35():262-269. PubMed ID: 31437741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower Urinary Tract Symptoms and Depression in Patients with Multiple Sclerosis.
    Tudor KI; Bošnjak Pašić M; Nađ Škegro S; Bakula M; Nemir J; Mustač F; Vidrih B; Pašić H; Vujević L; Rajič F; Tudor Car L
    Psychiatr Danub; 2020 Nov; 32(Suppl 4):511-519. PubMed ID: 33212457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon beta-1 a and depression in relapsing-remitting multiple sclerosis: an analysis of depression data from the PRISMS clinical trial.
    Patten SB; Metz LM
    Mult Scler; 2001 Aug; 7(4):243-8. PubMed ID: 11548984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal study of quality of life and side effects in patients with multiple sclerosis treated with interferon beta-1a.
    Zivadinov R; Zorzon M; Tommasi MA; Nasuelli D; Bernardi M; Monti-Bragadin L; Cazzato G
    J Neurol Sci; 2003 Dec; 216(1):113-8. PubMed ID: 14607312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptom cluster and quality of life: preliminary evidence in multiple sclerosis.
    Motl RW; McAuley E
    J Neurosci Nurs; 2010 Aug; 42(4):212-6. PubMed ID: 20804116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.